<--- Back to Details
First PageDocument Content
Medicine / Cancer / Clinical medicine / Papillomavirus / Vaccines / RTT / Infectious causes of cancer / Immunology / Virus-like particle / HPV vaccines / Immunogenicity / Human papillomavirus infection
Date: 2012-07-09 16:50:03
Medicine
Cancer
Clinical medicine
Papillomavirus
Vaccines
RTT
Infectious causes of cancer
Immunology
Virus-like particle
HPV vaccines
Immunogenicity
Human papillomavirus infection

The UNM Interdisciplinary HPV Prevention Center

Add to Reading List

Source URL: hpvprevention.unm.edu

Download Document from Source Website

File Size: 274,22 KB

Share Document on Facebook

Similar Documents

Universal detection reagent for immunogenicity assays EBF – Young Scientist Symposium 2015 Elli Oksanen

DocID: 1v3Ky - View Document

Induction of Tolerance to Immunotoxins Using Nanoparticle Delivery of Rapamycin Ronit Mazor and Ira Pastan Immunogenicity summit October 2016

DocID: 1uGDJ - View Document

Medicine / Cancer / Clinical medicine / Papillomavirus / Vaccines / RTT / Infectious causes of cancer / Immunology / Virus-like particle / HPV vaccines / Immunogenicity / Human papillomavirus infection

The UNM Interdisciplinary HPV Prevention Center

DocID: 1rtWC - View Document

Medicine / Biology / Clinical medicine / Biotechnology / Immunology / ActoBiotics / Autoimmune diseases / Bacteriology / Biopharmaceutical / Immunogenicity / Mucositis / Human microbiota

Overview ActoBiotics® Platform: A Novel Class of Oral Biotherapeutics

DocID: 1rtnN - View Document

Pharmaceutical sciences / Pharmacology / Business / Pharmaceutical industry / Pharmacy / Biotechnology / European Federation of Pharmaceutical Industries and Associations / Immunogenicity / Drug discovery / Novartis / Biopharmaceutical / Sanofi

ABIRISK ABIRISK Project Officially Started A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments for

DocID: 1rlyu - View Document